Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Nixon

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Methods in Enzymology|October 19, 2004
Analysis of the regulation of microtubule dynamics by interaction of RGSZ1 (RGS20) with the neuronal stathmin, SCG10Andrew B Nixon, Patrick J Casey
Cancer Informatics|August 16, 2014
Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian DataAndrew E Dellinger, Andrew B Nixon, Herbert Pang
The Journal of Biological Chemistry|March 8, 2002
The interaction of RGSZ1 with SCG10 attenuates the ability of SCG10 to promote microtubule disassemblyAndrew B Nixon, Gabriele Grenningloh, Patrick J Casey
Gynecologic Oncology|June 25, 2018
Cabozantinib in ovarian clear cell cancers: UnMET expectationsAngeles Alvarez Secord, Rebecca A Previs, Andrew B Nixon
Gynecologic Oncology|September 3, 2014
The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancerAngeles Alvarez Secord, Andrew B Nixon, Herbert I Hurwitz
Urologic Oncology|August 9, 2016
Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapiesTian Zhang, Jason Zhu, Daniel J George, et al.
International Journal of Molecular Sciences|December 30, 2020
Endoglin Targeting: Lessons Learned and Questions That RemainYingmiao Liu, Madelon Paauwe, Andrew B Nixon, et al.
Computers in Biology and Medicine|January 2, 2015
A leave-one-out cross-validation SAS macro for the identification of markers associated with survivalChristel Rushing, Anuradha Bulusu, Herbert I Hurwitz, et al.
Cancer Journal (Sudbury, Mass.)|July 30, 2015
Identifying Blood-Based Protein Biomarkers for Antiangiogenic Agents in the Clinic: A Decade of ProgressAce J Hatch, Jeffrey M Clarke, Andrew B Nixon, et al.
Hypertension (Dallas, Tex. : 1979)|August 5, 2009
Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expressionCarie S Facemire, Andrew B Nixon, Robert Griffiths, et al.
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Methods in Enzymology|October 19, 2004
Analysis of the regulation of microtubule dynamics by interaction of RGSZ1 (RGS20) with the neuronal stathmin, SCG10Andrew B Nixon, Patrick J Casey
Cancer Informatics|August 16, 2014
Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian DataAndrew E Dellinger, Andrew B Nixon, Herbert Pang
The Journal of Biological Chemistry|March 8, 2002
The interaction of RGSZ1 with SCG10 attenuates the ability of SCG10 to promote microtubule disassemblyAndrew B Nixon, Gabriele Grenningloh, Patrick J Casey
Gynecologic Oncology|June 25, 2018
Cabozantinib in ovarian clear cell cancers: UnMET expectationsAngeles Alvarez Secord, Rebecca A Previs, Andrew B Nixon
Gynecologic Oncology|September 3, 2014
The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancerAngeles Alvarez Secord, Andrew B Nixon, Herbert I Hurwitz
Urologic Oncology|August 9, 2016
Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapiesTian Zhang, Jason Zhu, Daniel J George, et al.
International Journal of Molecular Sciences|December 30, 2020
Endoglin Targeting: Lessons Learned and Questions That RemainYingmiao Liu, Madelon Paauwe, Andrew B Nixon, et al.
Computers in Biology and Medicine|January 2, 2015
A leave-one-out cross-validation SAS macro for the identification of markers associated with survivalChristel Rushing, Anuradha Bulusu, Herbert I Hurwitz, et al.
Cancer Journal (Sudbury, Mass.)|July 30, 2015
Identifying Blood-Based Protein Biomarkers for Antiangiogenic Agents in the Clinic: A Decade of ProgressAce J Hatch, Jeffrey M Clarke, Andrew B Nixon, et al.
Hypertension (Dallas, Tex. : 1979)|August 5, 2009
Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expressionCarie S Facemire, Andrew B Nixon, Robert Griffiths, et al.
Pageof 13